Amgen (AMGN) Cash from Operations Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
220.11% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-39.77% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
134.19% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
56.72% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
57.37% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
44.79% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
11.99% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-43.50% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
57.37% |
| Dec 31, 2025 |
-66.40% |
| Sep 30, 2025 |
31.17% |
| Jun 30, 2025 |
-7.28% |
| Mar 31, 2025 |
101.89% |
| Dec 31, 2024 |
786.80% |
| Sep 30, 2024 |
29.38% |
| Jun 30, 2024 |
-40.16% |
| Mar 31, 2024 |
-35.24% |
| Dec 31, 2023 |
-79.69% |
| Sep 30, 2023 |
-7.32% |
| Jun 30, 2023 |
112.90% |
| Mar 31, 2023 |
-50.83% |
| Dec 31, 2022 |
-5.66% |
| Sep 30, 2022 |
23.16% |
| Jun 30, 2022 |
-0.05% |
| Mar 31, 2022 |
2.85% |
| Dec 31, 2021 |
30.42% |
| Sep 30, 2021 |
-28.21% |
| Jun 30, 2021 |
-32.05% |
| Mar 31, 2021 |
-1.41% |
| Dec 31, 2020 |
-14.36% |
| Sep 30, 2020 |
-0.27% |
| Jun 30, 2020 |
100.99% |
| Mar 31, 2020 |
15.66% |
| Dec 31, 2019 |
-21.29% |
| Sep 30, 2019 |
3.18% |
| Jun 30, 2019 |
-32.73% |
| Mar 31, 2019 |
-32.34% |
| Dec 31, 2018 |
6.04% |
| Sep 30, 2018 |
-5.24% |
| Jun 30, 2018 |
-9.63% |
| Mar 31, 2018 |
14.34% |
| Dec 31, 2017 |
-2.84% |
| Sep 30, 2017 |
29.75% |
| Jun 30, 2017 |
-13.11% |
| Mar 31, 2017 |
24.54% |
| Dec 31, 2016 |
49.54% |
| Sep 30, 2016 |
-7.95% |
| Jun 30, 2016 |
-18.48% |
| Mar 31, 2016 |
29.22% |
| Dec 31, 2015 |
-27.06% |
| Sep 30, 2015 |
5.51% |
| Jun 30, 2015 |
47.46% |
| Mar 31, 2015 |
29.77% |
| Dec 31, 2014 |
54.88% |
| Sep 30, 2014 |
51.69% |
| Jun 30, 2014 |
39.19% |
| Mar 31, 2014 |
8.87% |
| Dec 31, 2013 |
125.99% |
| Sep 30, 2013 |
4.88% |
| Jun 30, 2013 |
-32.63% |
| Mar 31, 2013 |
7.92% |
| Dec 31, 2012 |
-48.74% |
| Sep 30, 2012 |
77.81% |
| Jun 30, 2012 |
54.62% |
| Mar 31, 2012 |
-5.63% |
| Dec 31, 2011 |
-21.12% |
| Sep 30, 2011 |
-25.58% |
| Jun 30, 2011 |
-1.79% |
| Mar 31, 2011 |
12.81% |
| Dec 31, 2010 |
10.15% |
| Sep 30, 2010 |
-34.08% |
| Jun 30, 2010 |
-6.85% |
| Mar 31, 2010 |
6.29% |
